Abstract
Diabetes is one of the most common chronic diseases worldwide. This study aims to evaluate the hypoglycemic and hypolipidemic effects of Crataegus aronia (C. aronia) ethanolic extract and Crataegus aronia phytosome (C. aronia-p) in streptozotocin (STZ)-induced diabetic rats. The phytochemical content of C. aronia was identified. The C. aronia ethanolic extract and C. aronia-p were checked for their antioxidant activity using DPPH assay. Then, in vivo evaluation of C. aronia ethanolic extract and C. aronia-p hypolipidemic and hypoglycemic activity was conducted using STZ-induced diabetic rats. The major phytochemicals component found in C. aronia ethanolic extract is phenols, flavonoids, alkaloids, and tannins. Moreover, The IC50 of DPPH scavenging activity after the treatment of C. aronia leaf ethanolic extract is 69.46±6.4 μl. Furthermore, our study indicated that the C. aronia leaves extract and C. aronia-p has significant hypolipidemic and hyperglycemic activity in the diabetic rats (P <0.001). This study provides a useful indication for promoting C. aronia as a potential novel therapeutic agent against diabetes.
Abstract from the paper’s OpenAlex record, shown for indexing and research. Copyright remains with the authors or the publisher. Read at the source ↗
The text the model read, with the source record’s inline markup (italics, sub- and superscripts) rendered and its character entities decoded; quote offsets refer to the raw text.
Claims 0
Judged off_topic: human health or diet — claims were not extracted. This is a scope decision by the model, not a statement about the paper’s findings.